Opinion
No. 13-71034
02-18-2015
NOT FOR PUBLICATION
Tax Ct. No. 3769-10 MEMORANDUM Appeal from a Decision of the Tax Court Submitted February 13, 2015 Pasadena California Before: CHRISTEN and HURWITZ, Circuit Judges, and BURGESS, District Judge.
This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2).
The Honorable Timothy M. Burgess, District Judge for the U.S. District Court for the District of Alaska, sitting by designation.
Ralph E. Holmes appeals from a Tax Court decision assessing deficiencies and penalties in connection with his returns for the years 2000 through 2004. Holmes challenges the Tax Court's finding that he was not entitled to defer recognition of gains pursuant to 26 U.S.C. § 1045. We have jurisdiction under 26 U.S.C. § 7482, and affirm.
1. We review the factual findings of the Tax Court for clear error. Boyd Gaming Corp. v. CIR, 177 F.3d 1096, 1098 (9th Cir. 1999).
2. The Tax Court did not clearly err in finding Holmes had failed to establish that he acquired the shares of LeonardoMD, Inc. at original issue. Holmes's testimony on this point was contradictory, and at one point he said that he acquired the shares from company officers. See 26 U.S.C. §§ 1045(b)(1), 1202(c)(1)(B); Ruark v. CIR, 449 F.2d 311, 313 (9th Cir. 1971) (per curiam).
3. Nor did the Tax Court clearly err in finding Holmes's conclusory and uncorroborated testimony insufficient to establish that at least 80% of LeonardoMD assets were used in the active conduct of qualified trades or businesses. See 26 U.S.C. §§ 1045(b)(1), 1202(c)(2)(A), (e)(1)(A); Geiger v. CIR, 440 F.2d 688, 689-90 (9th Cir. 1971) (per curiam).
Because we affirm on these bases, we need not address Holmes's challenge to the Tax Court's finding that he failed to establish LeonardoMD did not have more than $50 million in gross assets. See 26 U.S.C. §§ 1045(b)(1), 1202(d)(1).
--------
AFFIRMED.